The clinical effects of early APD were also verified in this study, which included releasing IAP, shortening the MV time, decreasing the WBC count and serum CRP, realizing an earlier half-dose EN, reducing later infections, and finally shortening the ICU stay and total hospitalization stay. This evidence concerns the gene CRP and infection.